Yifeng Pharmacy Chain (603939) Q1 2026 earnings summary

Executive summary

• Revenue for Q1 2026 reached RMB 6.09 billion, up 1.26% year-over-year.

• Net profit attributable to shareholders was RMB 499.55 million, an 11.14% increase year-over-year.

• 142 new stores opened (28 self-built, 114 franchised), 30 stores closed; net increase of 112 stores, totaling 14,943 stores at quarter-end.

Financial highlights

• Operating income rose to RMB 723.64 million, up 11.70% year-over-year.

• Basic EPS was RMB 0.41, up 10.81% year-over-year; diluted EPS was RMB 0.40, up 11.11%.

• Net cash flow from operating activities was RMB 1.06 billion, down 5.21% year-over-year.

• Total assets at quarter-end were RMB 27.45 billion, up 2.30% from year-end 2025.

Outlook and guidance

• Continued expansion of store network with a focus on both self-built and franchised stores.